Health
New N501Y SARS-CoV-2 mutations increase binding to host cell receptor – News-Medical.Net
A team of researchers used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus’s receptor-binding domain…
A team of researchers at Nanjing University in China used several assays, atomic force microscopy, and simulations to determine that the N501Y mutation in the virus’s receptor-binding domain (RBD) increased interaction of the virus with the angiotensin-converting enzyme 2 (ACE2) receptor.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, is an enveloped RNA virus. The spike protein, which has an amino-terminal…
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business22 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News20 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here